StockData
Johnson & Johnson logo

Johnson & Johnson (JNJ) stock

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3086% above fair value
$278.70−3.85 (-1.36%)

Close on Nov 17, 2026Market cap $670.92BP/E 42.3Yield 1.84%

Johnson & Johnson cash

Cash and short-term investments held at the end of each period.

Johnson & Johnson's cash was $17.23B at Sep 27, 2026. For fiscal 2025 it was $20.10B, down 18.0% from the year before. Over ten years it grew -6.3% a year on average. The highest annual figure on record is $41.91B in fiscal 2016.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 28, 2025$20.10B-18.0%
FY2024Dec 29, 2024$24.52B+7.0%
FY2023Dec 31, 2023$22.93B-2.5%
FY2022Jan 1, 2023$23.52B-25.6%
FY2021Jan 2, 2022$31.61B+25.5%
FY2020Jan 3, 2021$25.19B+30.6%
FY2019Dec 29, 2019$19.29B-2.0%
FY2018Dec 30, 2018$19.69B+7.6%
FY2017Dec 31, 2017$18.30B-56.3%
FY2016Jan 1, 2017$41.91B+9.2%
FY2015Jan 3, 2016$38.38B+16.0%
FY2014Dec 28, 2014$33.09B+13.3%
FY2013Dec 29, 2013$29.21B+38.5%
FY2012Dec 30, 2012$21.09B-34.6%
FY2011Jan 1, 2012$32.26B+16.6%
FY2010Jan 2, 2011$27.66B+74.9%
FY2009Jan 3, 2010$15.81B+46.8%
FY2008Dec 28, 2008$10.77B+38.6%
FY2007Dec 30, 2007$7.77B+90.3%
FY2006Dec 31, 2006$4.08B–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 27, 2026$17.23B-7.2%
Q2 FY2026Jun 28, 2026$20.76B+9.9%
Q1 FY2026Mar 29, 2026$22.05B-43.1%
Q4 FY2025Dec 28, 2025$20.10B-18.0%
Q3 FY2025Sep 28, 2025$18.56B-8.5%
Q2 FY2025Jun 29, 2025$18.88B-25.9%
Q1 FY2025Mar 30, 2025$38.78B+47.9%
Q4 FY2024Dec 29, 2024$24.52B+7.0%
Q3 FY2024Sep 29, 2024$20.30B-13.7%
Q2 FY2024Jun 30, 2024$25.48B-10.7%
Q1 FY2024Mar 31, 2024$26.22B-18.9%
Q4 FY2023Dec 31, 2023$22.93B-2.5%
Q3 FY2023Oct 1, 2023$23.51B-31.1%
Q2 FY2023Jul 2, 2023$28.51B-12.6%
Q1 FY2023Apr 2, 2023$32.32B+6.3%
Q4 FY2022Jan 1, 2023$23.52B-25.6%
Q3 FY2022Oct 2, 2022$34.13B+10.1%
Q2 FY2022Jul 3, 2022$32.61B+28.9%
Q1 FY2022Apr 3, 2022$30.41B+23.5%
Q4 FY2021Jan 2, 2022$31.61B+25.5%
Q3 FY2021Oct 3, 2021$31.00B+0.7%
Q2 FY2021Jul 4, 2021$25.31B+32.3%
Q1 FY2021Apr 4, 2021$24.62B+36.6%
Q4 FY2020Jan 3, 2021$25.19B+30.6%
Q3 FY2020Sep 27, 2020$30.78B+71.5%
Q2 FY2020Jun 28, 2020$19.13B+25.2%
Q1 FY2020Mar 29, 2020$18.02B+17.5%
Q4 FY2019Dec 29, 2019$19.29B-2.0%
Q3 FY2019Sep 29, 2019$17.94B-7.3%
Q2 FY2019Jun 30, 2019$15.28B-15.8%
Q1 FY2019Mar 31, 2019$15.34B+0.9%
Q4 FY2018Dec 30, 2018$19.69B+7.6%
Q3 FY2018Sep 30, 2018$19.36B+19.3%
Q2 FY2018Jul 1, 2018$18.14B+41.1%
Q1 FY2018Apr 1, 2018$15.20B-61.4%
Q4 FY2017Dec 31, 2017$18.30B-56.3%
Q3 FY2017Oct 1, 2017$16.23B–
Q2 FY2017Jul 2, 2017$12.85B–
Q1 FY2017Apr 2, 2017$39.34B–
Q4 FY2016Jan 1, 2017$41.91B–

More Johnson & Johnson figures

See a number that looks wrong?